Home » Stocks » CLCS

Cell Source, Inc. (CLCS)

Stock Price: $0.940 USD -0.005 (-0.53%)
Updated December 3, 4:00 PM EST - Market closed

CLCS Stock Price Chart

Key Info

Market Cap 30.04M
Revenue (ttm) n/a
Net Income (ttm) -4.72M
Shares Out 31.85M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $0.940
Previous Close $0.945
Change ($) -0.005
Change (%) -0.53%
Day's Open 0.950
Day's Range 0.890 - 0.950
Day's Volume 500
52-Week Range 0.000 - 0.950

CLCS Stock News

There are no news available yet.

About CLCS

Cell Source, a cell therapy company, focuses on developing and commercializing immunotherapy medicines in Israel. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma; and facilitating the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant or... [Read more...]

Industry
Biotechnology
Founded
2011
Employees
1
Stock Exchange
US OTC
Ticker Symbol
CLCS
Full Company Profile

Financial Performance

Financial Statements